Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.
about
Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationQuantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imagingPeripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceCommon pathways for receptor-mediated ingestion of Escherichia coli and LDL cholesterol by Entamoeba histolytica regulated in part by transmembrane kinase 39Intracellular uptake and trafficking of difluoroboron dibenzoylmethane-polylactide nanoparticles in HeLa cells.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Dynamics and mechanisms of quantum dot nanoparticle cellular uptake.Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particlesHuman stem cell delivery for treatment of large segmental bone defectsImportance of macrophage cholesterol content on the flux of cholesterol mass.Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis.The macrophage: the intersection between HIV infection and atherosclerosis.Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis.Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kγ-dependent fluid-phase pinocytosis of native LDL.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisDelivery of Quantum Dot-siRNA Nanoplexes in SK-N-SH Cells for BACE1 Gene Silencing and Intracellular Imaging.High-capacity selective uptake of cholesteryl ester from native LDL during macrophage foam cell formation.Labeling Cytosolic Targets in Live Cells with Blinking Probes.Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicingStandardization of models and methods used to assess nanoparticles in cardiovascular applications.Monocyte and macrophage dynamics during atherogenesis.Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation.Visualizing the atherosclerotic plaque: a chemical perspective.A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials.Eating the Dead to Keep Atherosclerosis at Bay.The immunology of atherosclerosis.Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1.Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types.Nanoblade delivery and incorporation of quantum dot conjugates into tubulin networks in live cells.Phenotypic high-throughput screening in atherosclerosis research: focus on macrophages.Increase in Dye:Dendrimer Ratio Decreases Cellular Uptake of Neutral Dendrimers in RAW Cells.Effects of engineered nanoparticles on the innate immune system.The surface chemistry determines the spatio-temporal interaction dynamics of quantum dots in atherosclerotic lesions.Measurement of Aortic Cell Fluid-Phase Pinocytosis in vivo by Flow Cytometry.Akt3 kinase suppresses pinocytosis of low-density lipoprotein by macrophages via a novel WNK/SGK1/Cdc42 protein pathway.Nano-selenium and its nanomedicine applications: a critical review.Exosomes from Human Dental Pulp Stem Cells Suppress Carrageenan-Induced Acute Inflammation in Mice.The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research.The nanotoxicology revolution.
P2860
Q21558503-082969C6-3294-4614-8E24-CDC1718C226EQ28478679-FB2208DF-7D86-4A82-A9F6-3D96462ECA9FQ28486624-983ABD18-1013-4F99-B553-18D2A29308F2Q30421582-175D817B-1E35-4963-8B82-B48CBE760F10Q30432232-2A7E10A2-0695-4575-824A-8E5617A69EF2Q30455490-C0633AF1-6E19-4F11-BDDB-C8E257859214Q30495337-354ECEC2-3178-4C7C-80D2-2A0F2A39DBC9Q30587665-0C963CC2-6461-49A1-9D85-AC6F21157B2DQ33734838-B8289069-E084-46B9-845D-D452A39A2680Q34188030-F834816B-1D17-458A-801D-824B8BFB7BE5Q34780877-644078A3-45A5-4F43-BF2A-C7665B3BBAE7Q34898069-A8B16A0A-458A-408A-8AD7-76D5195303D2Q35207040-24F07644-BAA8-4D05-A8E5-95FF5CAB02C6Q35627821-D9F5420B-D717-4E55-9C56-431BF6663609Q35710262-DA33537A-C43B-47D3-A8A6-7CEAF3801281Q36053948-C3A0122A-10C6-4E8B-ACDB-DD405C82D90BQ36213854-327AC7F4-5B36-44E8-9911-DBAB4B69FEF8Q37069991-B32CB48E-D060-43DA-998D-50149C8E9558Q37217500-FBB17CE9-3B01-4A5A-B6F0-746751F723BEQ37841416-F8755B04-4236-4195-9758-6A735ADE698EQ37890185-98E79EC8-3460-46DF-A40F-198D142A2653Q37985757-9086BC81-C7BA-48AB-A674-053ACFDFE790Q38187881-9D74E0CD-2C15-438E-9290-C037FD2FE118Q38665194-78F0FC61-1C81-4E63-B0C4-2E79AFF5F4A0Q39134393-FC71E207-0CF4-438A-9614-B558F60381C0Q39230390-0FF22435-B23B-4E3D-9D16-ECCA79BD1B14Q39255621-0CB61A43-9FE3-4784-A6A2-78095FCC9151Q39627941-41DBE08B-F02E-49B5-BBD1-71BF2FF479BEQ39663116-7C7087E4-4C77-484D-971B-7F8C97796523Q41408394-1EBD3136-2CA1-4C3C-A88F-DBB9FD6A9B22Q41838948-1203DDBF-C702-4D00-8B4D-0838B6D36D7EQ42317454-7363A9C9-73A9-452D-BC61-FD80665BDE48Q47685899-71F05D3D-185B-4105-A0B5-B7DC590676E2Q50046147-D590E4FB-27D8-4AEB-BE4D-5B6853BD4152Q50942934-D877DDDF-AA36-44C7-857D-810B4E1B3801Q51066750-2A240243-D11B-42C5-9164-B327BF3C2C9AQ52564739-395F1787-73A8-4E09-AF49-00998724EC84Q53530942-B2FE77FB-7FC1-4311-B5C0-AF6C56FBC517Q54402965-AEA012A5-D6C0-4528-8516-EC4DAE536348Q54645900-5D92B58B-5DAB-4754-BFB9-F121A68D3C7E
P2860
Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@en
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@nl
type
label
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@en
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@nl
prefLabel
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@en
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@nl
P2093
P2860
P921
P356
P1476
Fluorescent pegylated nanopart ...... mouse atherosclerotic lesions.
@en
P2093
Chiara Buono
Howard S Kruth
Joshua J Anzinger
Marcelo Amar
P2860
P304
P356
10.1172/JCI35548
P407
P577
2009-04-13T00:00:00Z